Des‐gamma‐carboxy prothrombin identified by <scp>P</scp>‐11 and <scp>P</scp>‐16 antibodies reflects prognosis for patients with hepatocellular carcinoma

Abstract

NX-PVKA offers the best marker of tumor prognosis among HCC patients, and is strongly associated with tumor factors and hepatic functional reserve. NX-PVKA could be useful for clinical evaluation of tumor severity, as well as the estimated duration of survival among patients with HCC.